#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Emphysema B-cell lymphoma Hereditary spastic paraplegia Immune thrombocytopenia Hepatitis D Cytomegalovirus infection Non-Hodgkin's lymphoma refractory Thrombotic microangiopathy Transitional cell cancer of the renal pelvis and ureter Peripheral primitive neuroectodermal tumour of soft tissue Palmar-plantar erythrodysaesthesia syndrome Leukocyte adhesion deficiency Methylmalonic acidaemia Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Biliary cancer metastatic More trials…

    Learn about Rare Diseases

    Breast angiosarcoma metastatic – Trials in Disease Ornithine transcarbamoylase deficiency – Life with Disease Chordoma – Basic Information Loeys-Dietz syndrome – Diagnostics Factor VIII deficiency – Trials in Disease Glycogen storage disease type I – Life with Disease Noonan syndrome – Basic Information Mucopolysaccharidosis I – Diagnostics Hepatoblastoma – Basic Information Aicardi-Goutieres syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Radotinib Dihydrochloride Lutetium (177Lu) Edotreotide Ertugliflozin Digitoxin Trastuzumab Emtansine Losartan Potassium Neridronate Sodium Ivermectin Emedastine Meclofenamate Sodium Eptacog Alfa (Activated) POTASSIUM HYDROXIDE Betula Pendula Pollen Extract Rosuvastatin Zinc Maribavir ORG-129 Immunglobulin Antipsychotics Lixisenatide Zidesamtinib More therapies…

    Learn about Your Condition

    Oedema Anxiety Urea cycle disorder Lymphangioleiomyomatosis Inflammatory bowel disease Petit mal epilepsy Vitamin D deficiency T-cell type acute leukaemia Rhabdoid tumour Thrombotic microangiopathy Mitral valve disease Lung adenocarcinoma stage III B-cell type acute leukaemia Acute respiratory failure Pterygium More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Coeliac disease

  • Study on ZED1227 for Improving Symptoms in Celiac Disease Patients on a Gluten-Free Diet

    Recruiting

    2 1
    Investigated Drugs:
    • Methyl (E,6S)-7-[[1-[2-(2-Ethylbutylamino)-2-Oxoethyl]-2-Oxopyridin-3-Yl]Amino]-6-[(3-Methylimidazole-4-Carbonyl)Amino]-7-Oxohept-2-Enoate
    Austria Croatia Finland Germany Ireland Italy +5

  • Evaluation of gaxilose (LacTEST 0.45 g) as a marker of intestinal barrier integrity in patients with celiac disease

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Coeliac disease
    Investigated Drugs:
    • GAXILOSE
    Spain

  • Study of TEV-53408 Safety and Effectiveness in Adults with Celiac Disease During Gluten Exposure

    Not recruiting

    2 1
    Investigated Diseases:
    • Coeliac disease
    Investigated Drugs:
    • TEV-53408
    Finland

  • Study on the Effects of Amlitelimab for Adults with Non-Responsive Celiac Disease

    Not recruiting

    2 1
    Investigated Drugs:
    • Amlitelimab
    Belgium Czechia Finland France Germany Greece +6

  • Study on the Effects of KAN-101 and Sodium Chloride in Adults with Celiac Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Coeliac disease
    Investigated Drugs:
    • Kan-101
    • Sodium Chloride
    Finland Germany Ireland The Netherlands Poland

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!